The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Long noncoding RNA BLACAT2 promotes bladder cancer–associated lymphangiogenesis and lymphatic metastasis
Open accessAbstract
The prognosis for bladder cancer patients with lymph node (LN) metastasis is dismal and only minimally improved by current treatment modalities. Elucidation of the molecular mechanisms that underlie LN metastasis may provide clinical therapeutic strategies for LN-metastatic bladder cancer. Here, we report that a long noncoding RNA LINC00958, which we have termed bladder cancer-associated transcript 2 (BLACAT2), was markedly upregulated in LN-metastatic bladder cancer and correlated with LN metastasis. Overexpression of BLACAT2 promoted bladder cancer-associated lymphangiogenesis and lymphatic metastasis in both cultured bladder cancer cell lines and mouse models. Furthermore, we demonstrate that BLACAT2 epigenetically upregulated VEGF-C expression by directly associating with WDR5, a core subunit of human H3K4 methyltransferase complexes. Importantly, administration of an anti-VEGF-C antibody inhibited LN metastasis in BLACAT2-overexpressing bladder cancer. Taken together, these findings uncover a molecular mechanism in the lymphatic metastasis of bladder cancer and indicate that BLACAT2 may represent a target for clinical intervention in LN-metastatic bladder cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia
Grebien, F., Vedadi, M., Getlik, M., Giambruno, R., Grover, A., Avellino, R., Skucha, A., Vittori, S., Kuznetsova, E., Smil, D., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1859 · Cited by 284 · cited 1×
“Multiple studies have recently documented that dysregulated WDR5 is involved in promoting cancer metastasis and chemoresistance (56, 57), suggesting that WDR5 may serve as a therapeutic target for cancer (58).”
Background
Cited by
Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer
Chen, C., Luo, Y., He, W., Zhao, Y., Kong, Y., Liu, H., Zhong, G., Li, Y., Li, J., Huang, J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130892 · Cited by 389
Self-citationXu, M., Xu, X., Pan, B., Chen, X., Lin, K., Zeng, K., Liu, X., Xu, T., Sun, L., Qin, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1063-6 · Cited by 290
Self-citation
Metadata
- Authors
- He, W., Zhong, G., Jiang, N., Wang, B., Fan, X., Chen, C., Chen, X., Huang, J., & Lin, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-01-22
- Volume
- 128
- Issue
- 2
- Pages
- 861-875
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2784977872
- Cited by
- 209
- References
- 1
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.